Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Value Demonstration and Access Considerations for Gene Therapies

Clark Paramore, MSPH. Bluebird bio, MA

Disclosures: C. Paramore: 1; Commercial Interest i.e. Company X; Bluebird bio. 1; What was received? i.e. Honorarium; Stock. 1; For what role? i.e. Speaker; Employee.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.